Karen Lund, MD
Dermatology · Plano, TXNPI 1225021645
Payments from drug & device makers
Across 545 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- AbbVie$1K
- EPI Health, LLC$1K
- Sun Pharmaceutical Industries Inc.$1K
- Lilly USA, LLC$965
- Regeneron Healthcare Solutions, Inc.$650
- plus $5K from 27 others
What the payments were for
- Speaking & faculty fees$1,0009%
- Food & beverage$10,09790%
- Education$881%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 63 | $1,357 |
| AbbVie(2 entities) | 71 | $1,174 |
| EPI Health, LLC | 5 | $1,065 |
| Sun Pharmaceutical Industries Inc. | 63 | $1,020 |
| Lilly USA, LLC | 47 | $965 |
| Regeneron Healthcare Solutions, Inc. | 27 | $650 |
| Dermavant Sciences, Inc. | 47 | $627 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 18 | $536 |
| Johnson & Johnson | 24 | $442 |
| Incyte Corporation | 21 | $409 |
| Sanofi | 21 | $408 |
| Galderma Laboratories, L.p. | 22 | $335 |
| Pfizer | 19 | $315 |
| VYNE Pharmaceuticals Inc. | 21 | $299 |
| LEO Pharma Inc. | 8 | $270 |
| UCB, Inc. | 11 | $208 |
| Almirall LLC | 11 | $182 |
| Amgen | 10 | $178 |
| Journey Medical Corporation | 1 | $161 |
| Mayne Pharma Commercial LLC | 9 | $103 |
| Encore Dermatology Inc. | 4 | $73 |
| Dermira, Inc. | 3 | $56 |
| Boehringer Ingelheim | 2 | $52 |
| Paratek Pharmaceuticals, Inc. | 3 | $48 |
| Octapharma USA, Inc. | 2 | $44 |
| Nabriva Therapeutics, PLC | 2 | $38 |
| Bristol Myers Squibb | 2 | $33 |
| Aclaris Therapeutics, Inc. | 2 | $33 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Sandoz | 1 | $22 |
| Glenmark Therapeutics Inc. | 2 | $22 |
| Taro Pharmaceuticals USA, Inc. | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,185 in reported general payments places this provider in the 70th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $48,356 |
| Tacrolimus | 46 | $6,890 |
| Fluocinonide | 136 | $4,682 |
| Clobetasol Propionate | 82 | $2,935 |
| ValacyclovirValacyclovir Hcl | 62 | $2,576 |
| Doxycycline Hyclate | 61 | $2,192 |
| Desonide | 73 | $2,141 |
| Metronidazole | 52 | $2,086 |
| Minocycline Hcl | 56 | $1,901 |
| Clindamycin Phosphate | 37 | $1,180 |
| Imiquimod | 20 | $533 |
| Hydroxyzine Hcl | 22 | $316 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $279 |
| Ketoconazole | 20 | $269 |
| Spironolactone | 12 | $253 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Plano
- Seemal DesaiPlano$1.1M
- Sam AwanPlano$586K
- Natalie WrightPlano$353K
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.